Myeloperoxidase deficiency: causes, symptoms, diagnosis, treatment
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Deficiency of myeloperoxidase is the most common congenital pathology of phagocytes, the incidence of complete hereditary myeloperoxidase deficiency is from 1: 1,400 to 1:12 000.
Hereditary deficiency of myeloperoxidase. The type of inheritance is autosomal recessive. Defects can be in structural or regulatory genes with a large variability of mutations. Myeloperoxidase is involved in the optimization of oxygen-dependent cytotoxicity, modulates the inflammatory response. Partial deficiency can be hereditary or acquired. Even with complete absence of myeloperoxidase, the phagocytosis and bactericidal activity of neutrophils are not violated, since for the destruction of microorganisms an MPO-independent system is used. At the same time, patients do not have candidal killer activity.
Hereditary deficiency of myeloperoxidase is asymptomatic, but there is a tendency to fungal infection, especially in patients with diabetes - to invasive mycoses.
With the deficiency of myeloperoxidase, treatment of infections is carried out according to general principles. Carefully prescribe antibiotics, especially with long courses. The forecast is favorable.
Prevention of myeloperoxidase deficiency is not carried out.
[What tests are needed?
Использованная литература